Testing and Diagnosing Andropause (Late-Onset Hypogonadism)
The diagnosis of andropause requires both biochemical confirmation with two early morning total testosterone measurements showing levels consistently <300 ng/dL AND the presence of specific symptoms such as decreased libido, erectile dysfunction, reduced energy, or loss of morning erections. 1
Required Laboratory Testing
Primary Hormone Measurements
Measure serum total testosterone on two separate occasions, both drawn in the early morning (before 10 AM), preferably using the same laboratory and methodology 1
Measure serum luteinizing hormone (LH) in all patients with confirmed low testosterone 1
Measure serum prolactin if LH is low or low-normal 1
Additional Testing Considerations
Measure follicle-stimulating hormone (FSH) to assess testicular function and spermatogenesis, particularly if fertility is a concern 3, 2
Consider measuring free testosterone or calculating free androgen index if total testosterone is borderline or clinical suspicion remains high despite normal total testosterone 4, 2
Clinical Symptom Assessment
Key Symptoms to Document
- Sexual symptoms: Reduced libido, erectile dysfunction, loss of morning penile tumescence 5, 6
- Physical symptoms: Reduced energy, decreased endurance, fatigue, diminished work/physical performance 1
- Cognitive/mood symptoms: Depression, reduced motivation, poor concentration, impaired memory, irritability 1
- Body composition changes: Decreased muscle mass, increased fat mass 2, 6
Physical Examination Findings
- Evaluate body habitus, body mass index or waist circumference 1
- Assess virilization status by examining body hair patterns in androgen-dependent areas 1
- Check for gynecomastia 1
- Perform testicular examination including presence, size, consistency, and masses 1
- Assess for varicocele 1
- Evaluate prostate size and morphology 1
High-Risk Populations Requiring Screening
Even without symptoms, measure testosterone in men with: 1
- Unexplained anemia
- Bone density loss or osteoporosis
- Diabetes mellitus
- History of chemotherapy exposure
- History of testicular radiation
- HIV/AIDS
- Chronic narcotic use
- Male infertility
- Pituitary dysfunction
- Chronic corticosteroid use
Important Caveats and Pitfalls
Questionnaires Are Not Diagnostic
- Do not use validated questionnaires as screening tools or to determine candidacy for testosterone therapy 1
- Questionnaires have variable sensitivity and specificity and should not replace comprehensive evaluation and laboratory testing 1
Assay Method Matters
- Use liquid chromatography-tandem mass spectrometry (LC-MS/MS) when available for superior accuracy in testosterone measurement 1, 7
- Direct immunoassays have lower accuracy and may produce inconsistent results 1, 7
- If immunoassay results are inconsistent with clinical presentation, recheck using LC-MS/MS 1, 7
Diabetes and Metabolic Factors
- Andropause occurs earlier and more frequently in diabetic men 5
- Duration of diabetes and HbA1c levels negatively impact testosterone levels 5
- Diabetic patients with low testosterone often have secondary hypogonadism (low LH) rather than primary testicular failure 5
- Obesity is a major confounder that can lower testosterone independent of age 8, 2
Fertility Considerations
- Never prescribe testosterone replacement to men desiring fertility, as it suppresses spermatogenesis 8
- For men wishing to preserve fertility with low testosterone and low/normal LH, consider selective estrogen receptor modulators instead 1
Diagnostic Algorithm Summary
- Document specific symptoms of hypogonadism (sexual, physical, cognitive) 1, 6
- Obtain two early morning total testosterone measurements on separate days 1
- If both values <300 ng/dL, measure LH 1
- If LH is low or low-normal, measure prolactin 1
- If prolactin elevated, repeat measurement and consider pituitary imaging if persistently elevated 1
- Perform targeted physical examination focusing on virilization, body composition, testicular size, and prostate 1
- Screen high-risk populations even without symptoms 1